Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of oral activated charcoal for reduction of uremic toxins in end-stage kidney disease
TCTR20260217008Phase 0Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of activated charcoal in end-stage kidney disease (ESKD), sponsored by Siriraj Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
activated charcoal
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20260217008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260217008.